Recombinant-activated factor VII for control and prevention of hemorrhage in nonhemophilic pediatric patients-Reference-Cited by-同舟云学术

Recombinant-activated factor VII for control and prevention of hemorrhage in nonhemophilic pediatric patients

Published:2010-06 Issue:4 Volume:21 Page:354-362
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:Blood Coagulation & Fibrinolysis

Author:

Chuansumrit Ampaiwan,Teeraratkul Sumate,Wanichkul Suthep,Treepongkaruna Suporn,Sirachainan Nongnuch,Pakakasama Samart,Nuntnarumit Pracha,Hongeng Suradej

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference25 articles.

1. A Cell-based Model of Hemostasis

2. Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.

3. Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors

4. Congenital factor VII deficiency: therapy with recombinant activated factor VII - a critical appraisal

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Site-directed mutagenesis of tissue factor pathway inhibitor–binding exosite D60A on factor VII results in a new factor VII variant with lower coagulant activity;Research and Practice in Thrombosis and Haemostasis;2024-01

2. Cost–utility analysis of an adjunctive recombinant activated factor VIIa for on-demand treatment of bleeding episodes in dengue haemorrhagic fever;Blood Coagulation & Fibrinolysis;2015-06

3. Overview of the use of recombinant factor VIIa in children;Pediatric Health, Medicine and Therapeutics;2014-10

4. Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment;Current Treatment Options in Infectious Diseases;2014-07-17

5. Acute coagulopathy in pediatric trauma;Current Opinion in Pediatrics;2014-06